Intratympanic Steroid Injection for Bell’s Palsy: Preliminary Randomized Controlled Study

Objective To investigate adjuvant effect and safety of intratympanic steroid for the treatment of Bell’s palsy. Study Design Prospective, investigator blinded, randomized study. Setting Tertiary referral center. Patients Patients who received treatment for Bell’s palsy from December 2007 to March 2011 were randomly divided into two groups. The control group (n = 17) was treated with systemic steroid plus antiviral agent, and intratympanic steroid injection group (IT group, n = 14) received intratympanic steroid injection combined with medications. Facial functions were evaluated on a regular basis up to 6 months. Intervention Intratympanic steroid injection. Main Outcome Measures Facial nerve functions of initial presentation and follow-up were evaluated with House-Brackmann (H-B) system. Primary outcome was complete recovery rate of 6 months. Secondary outcomes included improvement of H-B grade within 3 weeks, time of first improvement in facial function, and cumulative recovery rate. In addition, subgroup analysis of H-B grade over than IV was performed. Results Complete recovery rate was not different between groups. Time of first improvement was shorter in IT group (p = 0.043). And IT group had a better cumulative recovery rate (p = 0.041) and showed the significant improvement in H-B grade within 3 weeks compared with control group (p = 0.045). In severe facial palsy, complete recovery rate of IT group and control group were 80% and 50% (p = 0.16), and IT groups showed the significant facial improvement within 3 weeks (p = 0.025). And there were no major adverse effects of intratympanic injection. Conclusion Intratympanic steroid injection might be a safe and useful adjuvant treatment modality for Bell’s palsy.

[1]  S. Schwartz,et al.  Clinical Practice Guideline: Bell’s Palsy , 2013 .

[2]  V. Demarin,et al.  Peripheral facial weakness (Bell's palsy). , 2013, Acta clinica Croatica.

[3]  R. Filipo,et al.  Intratympanic steroid therapy in moderate sudden hearing loss: A randomized, triple‐blind, placebo‐controlled trial , 2013, The Laryngoscope.

[4]  G. Gronseth,et al.  Evidence-based guideline update: Steroids and antivirals for Bell palsy , 2012, Neurology.

[5]  M. Kanerva,et al.  Bell’s palsy – the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial , 2012, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[6]  M. Kanerva,et al.  The effect of prednisolone on sequelae in Bell's palsy. , 2012, Archives of otolaryngology--head & neck surgery.

[7]  S. Schwartz,et al.  Intratympanic Steroids for Sudden Sensorineural Hearing Loss , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[8]  J. Finsterer.  Management of peripheral facial nerve palsy , 2008, European Archives of Oto-Rhino-Laryngology.

[9]  M. Kaufman,et al.  Sir Charles Bell (1774-1842): contributions to neuro-ophthalmology. , 2007, Acta ophthalmologica Scandinavica.

[10]  P. Donnan,et al.  Early Treatment with Prednisolone or Acyclovir in Bell’s Palsy , 2007, The New England journal of medicine.

[11]  J. Tiemstra,et al.  Bell's palsy: diagnosis and management. , 2007, American family physician.

[12]  N. Surgery.  [Facial nerve grading system]. , 2006, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[13]  B. Sellhaus,et al.  Fallopian canal dehiscences: a survey of clinical and anatomical findings , 2005, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[14]  M. Álvarez,et al.  Corticosteroids for Bell's palsy (idiopathic facial paralysis). , 2002, The Cochrane database of systematic reviews.

[15]  D. Mccormick.  Herpes simplex virus as a cause of Bell's palsy. 1972. , 2000, Reviews in medical virology.

[16]  H. Slavkin.  The significance of a human smile: observations on Bell's palsy. , 1999, Journal of the American Dental Association.

[17]  D. López-Aguado,et al.  Incidence of dehiscences in the fallopian canal. , 1997, International journal of pediatric otorhinolaryngology.

[18]  H. Silverstein,et al.  Intratympanic Steroid Treatment of Inner Ear Disease and Tinnitus (Preliminary Report) , 1996, Ear, nose, & throat journal.

[19]  D. Zelterman,et al.  Prevalence of facial canal dehiscence and of persistent stapedial artery in the human middle ear: A report of 1000 temporal bones , 1994, The Laryngoscope.

[20]  H. Takahashi,et al.  Facial Canal Dehiscence: Histologic Study and Computer Reconstruction , 1992, The Annals of otology, rhinology, and laryngology.

[21]  E. Sakata,et al.  Treatment of vestibular disorders. , 1991, Acta oto-laryngologica. Supplementum.

[22]  F. L. Bryant.  Intratympanic injection of steroid for treatment of facial paralysis , 1973, The Laryngoscope.

[23]  D. Mccormick.  Herpes-simplex virus as a cause of Bell's palsy. , 1972, Lancet.

[24]  A. Baxter.  Dehiscence of the Fallopian canal An anatomical study , 1971, The Journal of Laryngology & Otology.

[25]  G. K. Dwyer.  Bell's palsy treated with cortisone. , 1955, Connecticut state medical journal.

[26]  R. Fimmers,et al.  Bell’s palsy , 2008, Journal of Neurology.